Summary & Overview
CPT 30100: Intranasal Biopsy for Tissue Diagnosis
CPT code 30100 denotes an intranasal biopsy — removal of a tissue sample from within the nasal cavity for diagnostic evaluation. Nasal biopsies are a key diagnostic tool for evaluating suspicious lesions, chronic inflammatory conditions, and suspected neoplasms of the nasal cavity and adjacent structures. Nationally, accurate coding for this procedure affects diagnostic pathways, clinical documentation, and appropriate claims processing.
Key payers included in this analysis are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of payer coverage considerations, common clinical contexts for use, and typical sites of service. The publication summarizes standard coding intent, common modifier usage (listed separately), and the procedural setting implications for ambulatory surgical centers, hospital outpatient departments, and office-based procedures.
The article provides practical benchmarks for how this diagnostic procedure is billed and categorized, highlights policy and documentation elements that influence reimbursement, and situates the code within clinical workflows for nasal pathology evaluation. Data not available in the input is noted where applicable.
Billing Code Overview
CPT code 30100 describes a procedure in which the provider removes a tissue sample from within the nasal cavity for pathologic investigation. This represents a nasal mucosal or intranasal biopsy performed to obtain tissue for diagnostic evaluation.
-
Service type: Diagnostic tissue biopsy
-
Typical site of service: Ambulatory surgical center, hospital outpatient department, or office-based procedure room depending on clinical setting and patient needs
Clinical & Coding Specifications
Clinical Context
A typical patient is a 45-year-old adult referred to an otolaryngology clinic for evaluation of unilateral nasal obstruction and intermittent epistaxis. After nasal endoscopy demonstrates a suspicious mucosal lesion on the lateral nasal wall, the provider performs a nasal biopsy to obtain tissue for histopathology and culture. The clinical workflow includes pre-procedure consent, topical and/or local anesthesia application in the clinic or procedure room, endoscopic or direct visualization, targeted tissue sampling using forceps or a biopsy punch, hemostasis control, specimen handling and labeling for pathology, and post-procedure instructions with follow-up to review results. The procedure is commonly performed in an outpatient clinic, ambulatory surgical center, or hospital outpatient department when additional monitoring or anesthesia services are required.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | Use when billing physician work separate from technical services (rare for simple nasal biopsies when facility bills technical component). |
51 | Multiple procedures | Use when multiple distinct procedures are performed the same day in addition to the biopsy. |